Eswatini vs Georgia: The number of people with susceptibility test result for rifampicin
Eswatini
953
in 2021
Georgia
953
in 2021
Eswatini rank
68th
Georgia rank
68th
The number of people with susceptibility test result for rifampicin over time
- Eswatini
- Georgia
How they compare
Eswatini currently reports 953 against 953 in Georgia, a difference of 0.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Eswatini ahead.
Eswatini ranks 68th and Georgia ranks 68th of 155 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,737 | 1,372 | 365.67 | Eswatini |
| 2020s | 1,028 | 1,008 | 20 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Eswatini or Georgia?
- Eswatini, at 953 against 953 in Georgia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Eswatini and Georgia?
- 0, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Georgia?
- 5 years are reported by both, from 2017 to 2021.
- How do Eswatini and Georgia rank globally for the number of people with susceptibility test result for rifampicin?
- Eswatini ranks 68th and Georgia ranks 68th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.